MARKER THERAPEUTICS INC.

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange MARKER THERAPEUTICS INC. stocks are traded under the ticker GX1.

MARKER THERAPEUTICS INC. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.

GX1 earnings for the last quarter are −0.32 EUR per share, whereas the estimation was −0.85 EUR resulting in a 62.22% surprise. The estimated earnings for the next quarter are −0.82 EUR per share. See more details about MARKER THERAPEUTICS INC. earnings.

MARKER THERAPEUTICS INC. revenue for the last quarter amounts to ‪754.30 K‬ EUR despite the estimated figure of ‪2.39 M‬ EUR. In the next quarter revenue is expected to reach ‪408.15 K‬ EUR.

Yes, you can track MARKER THERAPEUTICS INC. financials in yearly and quarterly reports right on TradingView.

No, GX1 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, GX1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MARKER THERAPEUTICS INC. stock right from TradingView charts — choose your broker and connect to your account.

GX1 reached its all-time high on Nov 14, 2002 with the price of 190.00 EUR, and its all-time low was 0.26 EUR and was reached on Dec 19, 2006. View more price dynamics on GX1 chart.
See other stocks reaching their highest and lowest prices.

As of May 2, 2024, the company has 8.00 employees. See our rating of the largest employees — is MARKER THERAPEUTICS INC. on this list?

We've gathered analysts' opinions on MARKER THERAPEUTICS INC. future price: according to them, GX1 price has a max estimate of 10.26 EUR and a min estimate of 10.26 EUR. Watch GX1 chart and read a more detailed MARKER THERAPEUTICS INC. stock forecast: see what analysts think of MARKER THERAPEUTICS INC. and suggest that you do with its stocks.